Crossmark

Reducing the effective dose of cisplatin using cobalt modified silver nano-hybrid as a carriers on MCF7 and HCT cell models

Published Online: 2024-04-10

Authors

Faid, Amna H.

Ramadan, Marwa A.
Funding

Funding for this research was provided by:

Cairo University
License Information

Text and Data Mining valid from 2024-04-10

Version of Record valid from 2024-04-10
More Information

Article History

Received: 7 June 2023

Accepted: 22 March 2024

First Online: 10 April 2024

Declarations

:

: Not applicable.

: Not Applicable.

: All the authors declare that they have no competing interests.

Document is current